PRESS RELEASEAB SCIENCE PRESENTS ITS ANNUAL FINANCIAL RESULTS AS OF 31 DECEMBER 2025 AND KEY EVENTS FOR THE PERIODFinancial and ...

It is within this landscape that functional medicine has emerged as one of the fastest-growing disciplines in American ...

Q1 2026 revenue of €197 million for YORVIPATH® and €44 million for SKYTROFA®- More than 1,000 new patient enrollments for YORVIPATH in the U.S.

Certain dietary patterns may reduce symptom severity by reducing inflammation and modulating hormone levels. RDs with ...

Vitamin B12 and healthy aging are now linked by striking new evidence from Cornell University. A landmark study published in ...

Mirum Pharmaceuticals, Inc. ("Mirum") , a leading rare disease company, today announced the pricing of its offering of $600.0 million aggregate principal amount of 0.00% convertible senior notes due ...

NeuroPace (NASDAQ:NPCE) raised its 2026 revenue outlook after reporting first-quarter results that management said reflected continued demand for its RNS System and improving commercial execution ...

Leading contributors in the Fund included Ultra Clean Holdings, Oil States International, Lincoln Educational Services, ...

The men at HBS inhabit a different reproductive universe from the women I wrote about in my previous article. Before they ...

Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...

Identifying a significant lag between project initiation and dissemination of research findings under the Ayurgyan scheme to generate credible scientific evidence for Ayush systems, the Parliamentary ...

Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the ...